ReviewPharmaceutics2023

Monoclonal Antibodies, Gene Silencing and Gene Editing (CRISPR) Therapies for the Treatment of Hyperlipidemia-The Future Is Here.

Melody Hermel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.